Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen

Bone Marrow Transplant. 1996 Jul;18(1):261.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Bone Marrow Transplantation*
  • Busulfan / adverse effects*
  • Chronic Disease
  • Cyclophosphamide / adverse effects*
  • Eosinophilia / epidemiology
  • Eosinophilia / etiology*
  • Graft vs Host Disease / blood*
  • Graft vs Host Disease / epidemiology
  • Graft vs Host Disease / prevention & control
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Leukemia / complications
  • Leukemia / therapy
  • Methylprednisolone / pharmacology
  • Methylprednisolone / therapeutic use
  • Transplantation Conditioning / adverse effects*
  • Transplantation, Homologous

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide
  • Busulfan
  • Methylprednisolone